Kathleen Gallagher

No open positions remaining

45 year

Health Technology

Consumer Services

Profile

Kathleen Gallagher is President, Chief Executive Officer & Director at Atrium Therapeutics, Inc. since 2026.
Formerly, Ms. Gallagher was Head-Communications at Merrimack Pharmaceuticals, Inc. from 2003 to 2016 and held the position of VP-Investor Relations & Corporate Communications at Akcea Therapeutics, Inc. Education includes undergraduate studies at Boston University.

Kathleen Gallagher active positions

Companies	Position	Start

All active positions of Kathleen Gallagher

Former positions of Kathleen Gallagher

Companies	Position	End
AVIDITY BIOSCIENCES, INC.	Investor Relations Contact	-
MERRIMACK PHARMACEUTICALS	Public Communications Contact	30/09/2016
AKCEA THERAPEUTICS, INC.	Investor Relations Contact	-

See the detail of Kathleen Gallagher's experience

Training of Kathleen Gallagher

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kathleen Gallagher's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Avidity Biosciences, Inc. Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merrimack Pharmaceuticals, Inc. Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer	Health Technology
Akcea Therapeutics, Inc. Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders	Health Technology